Aveo Group (ASX:AOG) to be removed from the S&P/ASX 200

Company News

by Rachael Jones

S&P Dow Jones announced today that it will remove the Aveo Group (ASX:AOG) from the S&P/ASX 200, subject to final court approval of the scheme of arrangement whereby the company will be acquired by Brookfield Asset Management.

Aveo investors have vote to sell the company to the Canadian investment firm for $2 billion.

Aveo Group will be replaced by Avita Medical (ASX:AVH) in the S&P/ASX 200 effective at the open on November 14, 2019.

Shares in Aveo Group (ASX:AOG) closed 0.47 per cent lower at $2.14 yesterday.

Are you a 708 sophisticated investor?

A sophisticated investor is defined under Section 708 of the Corporations Act (net assets of $2.5 million or annual incomes in excess of $250,000).

They are eligible to receive information regarding wholesale investment opportunities that are not available to regular or retail investors.

Please subscribe if you would like to be alerted to these types of opportunities.